BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38494554)

  • 1. Mononuclear η
    Kanyora AK; Omondi RO; Ongoma P; Omolo JO; Welsh A; Prince S; Gichumbi J; Mambanda A; Smith GS
    J Biol Inorg Chem; 2024 Mar; 29(2):251-264. PubMed ID: 38494554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-sandwich Ru(η
    Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
    J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
    Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
    J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrazole appended quinoline-BODIPY based arene ruthenium complexes: their anticancer activity and potential applications in cellular imaging.
    Paitandi RP; Sharma V; Singh VD; Dwivedi BK; Mobin SM; Pandey DS
    Dalton Trans; 2018 Dec; 47(48):17500-17514. PubMed ID: 30507985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity.
    Ganeshpandian M; Loganathan R; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Dalton Trans; 2014 Jan; 43(3):1203-19. PubMed ID: 24177707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding mode transformation and biological activity on the Ru(II)-DMSO complexes bearing heterocyclic pyrazolyl ligands.
    Dorairaj DP; Lin YF; Haribabu J; Murugan T; Narwane M; Karvembu R; Neelakantan MA; Kao CL; Chiu CC; Hsu SCN
    J Inorg Biochem; 2021 Oct; 223():111545. PubMed ID: 34303108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarities and differences in d
    Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E
    J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly Cytotoxic Ruthenium(II)-Arene Complexes from Bulky 1-Pyrenylphosphane Ligands.
    Brissos RF; Clavero P; Gallen A; Grabulosa A; Barrios LA; Caballero AB; Korrodi-Gregório L; Pérez-Tomás R; Muller G; Soto-Cerrato V; Gamez P
    Inorg Chem; 2018 Dec; 57(23):14786-14797. PubMed ID: 30444630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of
    Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
    Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luminescent naphthalimide-tagged ruthenium(ii)-arene complexes: cellular imaging, photocytotoxicity and transferrin binding.
    Srivastava P; Verma M; Kumar A; Srivastava P; Mishra R; Sivakumar S; Patra AK
    Dalton Trans; 2021 Mar; 50(10):3629-3640. PubMed ID: 33625414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution equilibrium, structural and cytotoxicity studies on Ru(η
    Dömötör O; Kiss MA; Gál GT; May NV; Spengler G; Nové M; Gašparović AČ; Frank É; Enyedy ÉA
    J Inorg Biochem; 2020 Jan; 202():110883. PubMed ID: 31689626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes.
    Kavukcu SB; Şahin O; Seda Vatansever H; Kurt FO; Korkmaz M; Kendirci R; Pelit L; Türkmen H
    Bioorg Chem; 2020 Jun; 99():103793. PubMed ID: 32278205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium(II) Diphosphine Complexes with Mercapto Ligands That Inhibit Topoisomerase IB and Suppress Tumor Growth In Vivo.
    da Silva MM; Ribeiro GH; de Camargo MS; Ferreira AG; Ribeiro L; Barbosa MIF; Deflon VM; Castelli S; Desideri A; Corrêa RS; Ribeiro AB; Nicolella HD; Ozelin SD; Tavares DC; Batista AA
    Inorg Chem; 2021 Sep; 60(18):14174-14189. PubMed ID: 34477373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole Ligands That Inhibit VEGFR2 Phosphorylation.
    Chakraborty A; Roy S; Chakraborty MP; Roy SS; Purkait K; Koley TS; Das R; Acharya M; Mukherjee A
    Inorg Chem; 2021 Dec; 60(23):18379-18394. PubMed ID: 34780170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos = bis-[(2-diphenylphosphino)phenyl]ether).
    Grawe GF; Oliveira KM; Leite CM; de Oliveira TD; Costa AR; Moraes CAF; Honorato J; Cominetti MR; Castellano EE; Correa RS; Machado SP; Batista AA
    J Inorg Biochem; 2023 Jul; 244():112204. PubMed ID: 37004320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA targeting half sandwich Ru(II)-
    Mondal A; Sen U; Roy N; Muthukumar V; Sahoo SK; Bose B; Paira P
    Dalton Trans; 2021 Jan; 50(3):979-997. PubMed ID: 33355328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer and antibacterial potential of robust Ruthenium(II) arene complexes regulated by choice of α-diimine and halide ligands.
    Zanda E; Busto N; Biancalana L; Zacchini S; Biver T; Garcia B; Marchetti F
    Chem Biol Interact; 2021 Aug; 344():109522. PubMed ID: 34029541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
    Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
    Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
    [TBL] [